Transdigm (TDG) Tops Q2 EPS by 10c; Updates FY15 Outlook
Get Alerts TDG Hot Sheet
Price: $1,246.31 +0.88%
Financial Fact:
COST OF SALES: 390.9M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
COST OF SALES: 390.9M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Transdigm (NYSE: TDG) reported Q2 EPS of $2.11, $0.10 better than the analyst estimate of $2.01. Revenue for the quarter came in at $619 million versus the consensus estimate of $631.61 million.
Transdigm sees FY2015 EPS of $8.49-$8.75, versus the consensus of $8.46. Transdigm sees FY2015 revenue of $2.66-2.69 billion, versus the consensus of $2.66 billion.
For earnings history and earnings-related data on Transdigm (TDG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- Swarmer, Inc (SWMR) Reports Q2 Loss of $0.45
- Sensus Healthcare, Inc. (SRTS) Misses Q2 EPS by 41c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share